T. Rowe Price Associates’s Caris Life Sciences, Inc. Common Stock CAI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$181M	Buy	+6,760,804	New	+$181M	0.02%	448